Predicting responses to chemotherapy in the context that matters - the patient

Guided by the belief that the most important setting for understanding tumor response to drugs is the human patient, we developed a technology called CIVO. CIVO enables analysis of up to 8 therapies simultaneously in a patient's tumor, without inducing systemic toxicity and while maintaining th...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreno-Gonzalez, Alicia, Olson, James M., Klinghoffer, Richard A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845209/
https://www.ncbi.nlm.nih.gov/pubmed/27308571
http://dx.doi.org/10.1080/23723556.2015.1057315
_version_ 1782428895721553920
author Moreno-Gonzalez, Alicia
Olson, James M.
Klinghoffer, Richard A.
author_facet Moreno-Gonzalez, Alicia
Olson, James M.
Klinghoffer, Richard A.
author_sort Moreno-Gonzalez, Alicia
collection PubMed
description Guided by the belief that the most important setting for understanding tumor response to drugs is the human patient, we developed a technology called CIVO. CIVO enables analysis of up to 8 therapies simultaneously in a patient's tumor, without inducing systemic toxicity and while maintaining the integrity of the native tumor microenvironment.
format Online
Article
Text
id pubmed-4845209
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-48452092016-06-15 Predicting responses to chemotherapy in the context that matters - the patient Moreno-Gonzalez, Alicia Olson, James M. Klinghoffer, Richard A. Mol Cell Oncol Author's View Guided by the belief that the most important setting for understanding tumor response to drugs is the human patient, we developed a technology called CIVO. CIVO enables analysis of up to 8 therapies simultaneously in a patient's tumor, without inducing systemic toxicity and while maintaining the integrity of the native tumor microenvironment. Taylor & Francis 2015-06-10 /pmc/articles/PMC4845209/ /pubmed/27308571 http://dx.doi.org/10.1080/23723556.2015.1057315 Text en © 2016 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.
spellingShingle Author's View
Moreno-Gonzalez, Alicia
Olson, James M.
Klinghoffer, Richard A.
Predicting responses to chemotherapy in the context that matters - the patient
title Predicting responses to chemotherapy in the context that matters - the patient
title_full Predicting responses to chemotherapy in the context that matters - the patient
title_fullStr Predicting responses to chemotherapy in the context that matters - the patient
title_full_unstemmed Predicting responses to chemotherapy in the context that matters - the patient
title_short Predicting responses to chemotherapy in the context that matters - the patient
title_sort predicting responses to chemotherapy in the context that matters - the patient
topic Author's View
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845209/
https://www.ncbi.nlm.nih.gov/pubmed/27308571
http://dx.doi.org/10.1080/23723556.2015.1057315
work_keys_str_mv AT morenogonzalezalicia predictingresponsestochemotherapyinthecontextthatmattersthepatient
AT olsonjamesm predictingresponsestochemotherapyinthecontextthatmattersthepatient
AT klinghofferricharda predictingresponsestochemotherapyinthecontextthatmattersthepatient

Ejemplares similares